Endpoints News

Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience

→ Michelle Werner has stepped down as CEO of Flagship startup Alltrna, saying on LinkedIn that the decision “is the right one for me and my family,” and she’s headed to Ipsen as president of North America on March 23. She closes out a four-year tenure after joining Alltrna and Flagship from Novartis, where she was the global franchise head for solid tumors. Werner had worked on advancing a pipeline of tRNA assets at the startup, with a lead program currently in IND-enabling studies.

This report was first published by Endpoints News. To see the original version, click here

Michelle Werner

Michelle Werner has stepped down as CEO of Flagship startup Alltrna, saying on LinkedIn that the decision “is the right one for me and my family,” and she’s headed to Ipsen as president of North America on March 23. She closes out a four-year tenure after joining Alltrna and Flagship from Novartis, where she was the global franchise head for solid tumors. Werner had worked on advancing a pipeline of tRNA assets at the startup, with a lead program currently in IND-enabling studies.

您已阅读6%(592字),剩余94%(9163字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×